We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Urinary Metabolite GWAS Leads to Biomarkers of Kidney Disease

By LabMedica International staff writers
Posted on 04 Feb 2020
Print article
Image: Histopathology of kidney disease: showing completely sclerotic glomeruli and severe chronic tubulointerstitial nephritis (Photo courtesy of Jian-Hua Qiao, MD, FCAP).
Image: Histopathology of kidney disease: showing completely sclerotic glomeruli and severe chronic tubulointerstitial nephritis (Photo courtesy of Jian-Hua Qiao, MD, FCAP).
The kidneys integrate information from continuous systemic processes related to the absorption, distribution, metabolism and excretion (ADME) of metabolites. Scientists have identified ties between urine metabolite levels and common genetic variants, laying the foundation for a more refined view of human metabolic processes and the tissues in which they take place.

Prior studies suggest that tissues from several key organs, from the liver and kidneys to the blood and intestinal tract, have a part to play in different aspects of ADME. It is suspected that there might be much more to learn about metabolism by testing urine samples in individuals with lower-than-usual metabolite detoxification and transport in the kidney's proximal tubules due to existing kidney conditions.

Scientists from the University of Freiburg (Freiburg, Germany) performed a genome-wide association study (GWAS) involving 1,627 individuals with diminished kidney function, searching for genetic loci coinciding with urine metabolite concentrations. Included in the study were urinary concentrations of 1,172 metabolites. The metabolic GWAS (mGWAS) led to 240 loci with apparent ties to urine metabolite concentrations, while their follow-up fine-mapping and single-cell expression analyses helped focus in on potential disease-causing genes, the cell types involved, and the urinary metabolites that may flag genetic predisposition to kidney disease.

The 240 unique metabolite–locus associations (metabolite quantitative trait loci, mQTLs) that were identified and replicated highlight novel candidate substrates for transport proteins. The identified genes are enriched in ADME-relevant tissues and cell types, and they reveal novel candidates for biotransformation and detoxification reactions. Fine mapping of mQTLs and integration with single-cell gene expression permitted the prioritization of causal genes, functional variants and target cell types. The combination of mQTLs with genetic and health information from 450,000 UK Biobank participants illuminated metabolic mediators, and hence, novel urinary biomarkers of disease risk.

The authors concluded that this comprehensive resource of genetic targets and their substrates is informative for ADME processes in humans and is relevant to basic science, clinical medicine and pharmaceutical studies. The study was published on January 20, 2020 in the journal Nature Genetics.

Related Links:
University of Freiburg

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.